Bellicum Pharmaceuticals Inc. buy stratec
Start price
02.12.18
/
50%
€43.84
Target price
12.11.19
€72.16
Performance (%)
-82.55%
End price
12.11.19
€7.65
Summary
This prediction ended on 12.11.19 with a price of €7.65. The BUY prediction by stratec for Bellicum Pharmaceuticals Inc. performed very badly with a performance of -82.55%. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bellicum Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
Comments by stratec for this prediction
In the thread Bellicum Pharmaceuticals Inc. diskutieren
Bellicum is treating patients with acute lymphocytic leukemia (ALL)
Bellicum Pharmaceuticals' Lead Drug Shows 91% Remission In Leukemia With 94% Survival; 100% Response In Rare Blood Disorders
Stopped prediction by stratec for Bellicum Pharmaceuticals Inc.
Bellicum Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€6.75
08.03.20
08.03.20
€12.00
21.03.20
21.03.20
-49.63%
21.03.20
21.03.20
Bellicum Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.80
23.02.20
23.02.20
€12.00
08.03.20
08.03.20
-1.54%
08.03.20
08.03.20
Bellicum Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.20
08.02.20
08.02.20
€12.00
22.02.20
22.02.20
-23.53%
22.02.20
22.02.20
Bellicum Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€12.20
06.01.20
06.01.20
€20.00
08.02.20
08.02.20
-16.39%
08.02.20
08.02.20
Bellicum Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.65
12.11.19
12.11.19
€10.00
31.12.19
31.12.19
55.56%
31.12.19
31.12.19
Bellicum Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€84.25
04.01.18
04.01.18
€180.40
03.12.18
03.12.18
-47.97%
03.12.18
03.12.18